Skip to main navigation PPD Inc Main Menu INVESTORS Overview Stock Information News & Events Financial Information Corporate Governance Investor Resources OVERVIEW PPD is dedicated to helping customers deliver life-changing therapies to patients by bending the cost and time curve of drug development and optimizing value. Committed to global operational excellence, we deploy a comprehensive suite of solutions, generating evidence to demonstrate effectiveness, safety and value. Passionate about improving health, we are defined by our people, more than 30,000 strong, whose talent, ingenuity and commitment are our formula for customer satisfaction. Leveraging patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, a novel approach to site and patient access, and comprehensive lab services via PPD® Laboratories. We serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships, functional service partnerships and PPD® Biotech, for biotech and small to midsize pharma companies. In an increasingly complex research landscape, biopharmaceutical leaders can depend on PPD for quality performance, continual innovation and trusted partnership. PPD: Dedicated to helping deliver life-changing therapies ANNUAL REPORT 2020 Annual Report INVESTOR CONTACT Tracy Krumme Vice President, Head of Investor Relations +1 910 558 4186 investors@ppd.com NEWS RELEASES PPD Wins Multiple Awards at Clinical Researcher of the Year Competition Nov 22, 2021 WILMINGTON, N.C. --(BUSINESS WIRE)--Nov. 22, 2021-- PPD, Inc. (Nasdaq: PPD ) earned numerous honors at the 2021 PharmaTimes Clinical Researcher of the Year-The Americas competition. Two PPD teams won gold, one team won silver and another team took home bronze. VIEW ALL QUARTERLY RESULTS Q1 2021 PPD Earnings Conference Call EVENTS AND PRESENTATIONS Oct 28, 2021 at 8:00 AM EDT Q3 2021 PPD Earnings Conference Call Jul 29, 2021 at 7:00 AM EDT Q2 2021 PPD Earnings Conference Call Apr 28, 2021 at 8:00 AM EDT Q1 2021 PPD Earnings Conference Call VIEW ALL PPD COMMON STOCK NASDAQ GS: PPD Price $47.30 Change +0.01 (+0.02%) Today's High $47.30 Nov 24, 2021 4:00 PM EST Data Provided by Refinitiv. Minimum 15 minutes delayed. Print Page Email Alerts RSS Feeds Email Page Legal Notices Site Map Modern Slavery Transparency Statement Privacy Policy ©2021 PPD. All Rights Reserved. LinkedIn Twitter Facebook Instagram YouTube Contact Us By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Accept All Cookies Cookies Settings